Document is current
Any future updates will be listed below
-
Authors
Richards, Sarah E. V.
Yang, Maddie
Deik, Amy A.
Ricq, Emily L. https://orcid.org/0000-0002-5819-7956
-
Funding
Funding for this research was provided by:
National Institute on Aging (R21 AG068769-01)
- License Information
-
More Information
Article History
Received: 20 March 2025
Revised: 6 June 2025
Accepted: 10 June 2025
First Online: 26 June 2025
Declarations
:
: All procedures involving animals were reviewed and approved by the Institutional Animal Care and Use Committee of the Broad Institute, IACUC protocol number: 0234-02-19.
: E.L.R. became an employee of Kisbee Therapeutics while work was being completed on this project and manuscript. Kisbee Therapeutics is developing optimized recombinant apoE lipoproteins to treat neurodegenerative diseases. Other authors declare no conflict of interest relevant to this study.
